4.Solution space of pharmacokinetics and its application on mice brain with 18F-FECNT
Guo-xian, CAO ; Zheng-ping, CHEN ; Xing-qin, ZHOU
Chinese Journal of Nuclear Medicine 2011;31(4):255-258
Objective To forward the concept of solution space of pharmacokinetics for studying radiophannaceutical distributions in animal models. Methods On the basis of special solutions of differential equations of pharmacokinetics, the solution space was established using the characteristics of linearly independent particular solutions and used to express the pharmacokinetics of pharmaceuticals in vivo. 0. 2 ml (7.4 MBq) 2β-carbomethoxy-3β- (4-corophenyl)-8-(2-18F-fluoroethyl) nortropane (18F-FECNT) was injected through tail vein into normal mice. The mice were sacrificed by decapitation at 5, 15, 30, 60, 120 and 180 min post-injection. Brain tissues were removed and weighed, and radioactivity was counted with the γ-counter. The solution space theory was used to study pharmacokinetics of 18F-FECNT in brain tissues of mice. Results The result showed that all solutions of pharmacokinetics models, based on differential equations, were included in the solution space. The solution of any organ or tissue could be linearly expressed by bases of the solution space. When the dimension number of the solution space was no more than 3, the solution could be directly expressed with coordinate picture. By this rule in our theory, the quantity of 18F-FECNT in brain tissues of mice changed with time, which was accorded with the experiment. The coordinates of striatum, frontal cortex, temporal cortex, occipital cortex, parietal cortex, hippocampus and cerebellum in the solution space were ( 10.13, 1.49), (4.27, 0. 84), (4.48, 0.81 ), (2.89, 0.98), (3.65, 0. 83),(3.55, 0. 98) and (2.03, 1.25 ), respectively. Conclusion The theory of solution space could be used to study pharmacokinetics of 18 F-FECNT in mice brain.
5.Clinical study on effects of tiepi fengdou granule/capsule combined with chemotherapy and/or radiotherapy in treating lung cancer with Qi-Yin asthenia syndrome.
Xiao-ping CHEN ; Yi-ping ZHANG ; Xian-ru ZHU
Chinese Journal of Integrated Traditional and Western Medicine 2006;26(5):394-397
OBJECTIVETo study the clinical efficaly and safety of Tiepi Fengdou Granule (TFG) and Capsule (TFC) combined with chemotherapy and/or radiotherapy in treating lung cancer patients with Qi-Yin asthenia syndrome (QYAS).
METHODSEighty patients were randomly assigned into 3 groups: the TFG group (32 cases), the TFC group (32 cases) and the Shengmai Capsule control group (16 cases). Changes of symptoms of QYAS, main symptoms of lung cancer, Karnofsky scoring as well as the blood routine test were observed.
RESULTSThe total effective rate of symptom improving in the TFG group and the TFC group was 81.2% and 93.3% respectively, showing insignificant difference between the 2 groups (P > 0.05), but both were higher than that in the Shengmai Capsule control group (50.0%, P < 0.05 and P < 0.01). Additionally, as compared with those before treatment, the neutrophil count increased and the lymphocytes count obviously decreased in the TFC group after treatment (all P < 0.05).
CONCLUSIONBoth dose-forms of the remedies, TFC and TFG, have significant effects in treating lung cancer with QYAS, but with insignificant difference between them.
Adult ; Antineoplastic Combined Chemotherapy Protocols ; therapeutic use ; Combined Modality Therapy ; Diagnosis, Differential ; Drugs, Chinese Herbal ; administration & dosage ; Female ; Humans ; Karnofsky Performance Status ; Lung Neoplasms ; drug therapy ; radiotherapy ; Male ; Medicine, Chinese Traditional ; Middle Aged ; Phytotherapy ; Qi ; Yin Deficiency ; drug therapy
6.Expression and significance of erythropoietin in human gastric carcinoma on tissue microarry.
Chen JIANG ; Jian-xian YU ; Hua CHEN ; Hong-jun WEI ; Hai-yan MA ; Ping JI
Chinese Journal of Pathology 2006;35(9):559-560
Adenocarcinoma
;
metabolism
;
pathology
;
Adenocarcinoma, Mucinous
;
metabolism
;
pathology
;
Adult
;
Aged
;
Aged, 80 and over
;
Carcinoma, Signet Ring Cell
;
metabolism
;
pathology
;
Erythropoietin
;
metabolism
;
Humans
;
Hypoxia-Inducible Factor 1, alpha Subunit
;
metabolism
;
Immunohistochemistry
;
Lymphatic Metastasis
;
Microvessels
;
chemistry
;
pathology
;
Middle Aged
;
Stomach
;
chemistry
;
pathology
;
Stomach Neoplasms
;
metabolism
;
pathology
;
Tissue Array Analysis
;
methods
7.Expression of cytokines in CD8~+ T lymphocytes of the peripheral blood of patients with condyloma acuminatum
Dong-Xian LIU ; Wen JIANG ; Xing-Ping CHEN ; Ying-Ling CHEN ; Dong-Liang YANG ;
Chinese Journal of Dermatology 2003;0(11):-
Objective To detect the levels of cytokine IL-2,IL-12,IFN-?and IL-4 secreted by peripheral CD8~+ T lymphocytes in patients with condyloma acuminatum (CA).Methods Flow cytometry was employed to study the expression of cytokines IL-2,-12,INF-?and IL-4 in CD8~+ T lymphocytes in the peripheral blood of 60 patients with CA and 20 healthy controls.Results The percentage of CD8~+ T lym- phocytes producing IL-2,IL-12 and IFN-?were significantly lower in CA patients than that in healthy con- trols (P
9.Congenital malignant melanoma in a neonate.
Hai-ping ZHANG ; Shan ZHONG ; Xian-yi JIANG ; Ming-ni YANG ; Pei-qiong CHEN
Chinese Journal of Pathology 2005;34(1):57-58
Follow-Up Studies
;
Forearm
;
Humans
;
Infant, Newborn
;
Male
;
Melanoma
;
congenital
;
surgery
;
Skin Neoplasms
;
congenital
;
surgery
10.Evaluation on Efficacy and Safety of Jinying Capsule in Treatment of Pelvic Inflammatory Disease Patients with Accumulated Damp-heat Syndrome.
Qin LI ; Chun-yan CHEN ; Yu-ping SUO ; Min HUANG ; Xian-hua HUANG
Chinese Journal of Integrated Traditional and Western Medicine 2015;35(12):1459-1462
OBJECTIVETo evaluate the efficacy and safety of Jinying Capsule (JC) in treating pelvic inflammatory disease patients with accumulated damp-heat syndrome (ADHS).
METHODSTotally 328 patients were recruited in a prospective, positive drug parallel controlled, and multi-center clinical trial. Of them 213 patients in the treatment group took JC (0.5 g per capsule), 4 capsules each time, 3 times per day, while 115 patients in the control group took Kangfuyan Capsule (KC, 0.4 g per capsule), 3 capsules each time, twice per day. The course of treatment was 4 weeks for all. Scores of Chinese medical syndromes, visual analogue scale (VAS) of the lower abdominal pain, and European quality of life-five dimension scale (EQ-5D) were observed before treatment and after 4 weeks of treatment.
RESULTSThere were 204 patients in the treatment group and 109 in the control group who completed this trial. The total effective rate of Chinese medical syndrome was 89.71% (183/204 cases) in the treatment group and 76.15% (83/109 cases) in the control group (P < 0.01). Compared with before treatment in the same group, EQ-5D scores increased, and VAS scores of the lower abdominal pain decreased in the two groups after treatment. EQ-5D scores was 0.857 ± 0.157 in the treatment group, obviously higher than that in the control group (0.753 ± 0.126, P < 0.05). VAS scores of the lower abdominal pain was 2.14 ± 1.23 in the treatment group, lower than that in the control group (2.33 ± 1.24), but with no statistical difference between the two groups (P > 0.05). No adverse reaction occurred in the two groups.
CONCLUSIONJC was superior to KC in improving Chinese medical syndrome and quality of life of pelvic inflammatory disease patients with accumulated damp-heat syndrome.
Capsules ; Drugs, Chinese Herbal ; therapeutic use ; Female ; Hot Temperature ; Humans ; Medicine, Chinese Traditional ; Pelvic Inflammatory Disease ; drug therapy ; Phytotherapy ; Prospective Studies ; Quality of Life ; Safety ; Syndrome